Skip To Main Content
MD PhD on Muck Rack

MD PhD

As seen in: The Lancet, Canadian Medical Association Journal, HemOnc Today, OSLI Retina, The British Journal of Psychiatry, The Journal of Allergy & Clinical Immunology, OncLive, European Journal of Cancer, EJSO - European Journal of Surgical Oncology, The International Journal of Antimicrobial Agents
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with MD

Contact MD, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: a mathematical model

|
By Julie Perry, Karen Cross Verified, MD PhD, Chris Boodoo
| cmajopen.ca
Background: One of the most common (and costly) complications of diabetes are diabetic foot ulcers, which often result in lower-extremity amputation. Regular foot care can reduce complications; however, roughly half of Canadians with diabetes do not participate in screening. We sought to evaluate the economic effects of using telemonitoring for diabetic foot ulcer prevention using mathematical modelling.
Open in Who Shared Issue with article?

Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema

|
By Glenn Noronha, MD PhD
| OSLI Retina Verified
Pharmaceuticals delivered by intravitreal injection have revolutionized the management of the most common causes of blindness in developed countries, including diabetic macular edema (DME), neovascular age-related macular degeneration, and retinal venous occlusive disease (RVO). 1 Current medications encompass two classes: anti-vascular endothelial growth factor (VEGF)-A and corticosteroid agents.
Open in Who Shared Issue with article?

Comparison of cardiac surgery mortality reports using administrative and clinical data sources: a prospective cohort study

|
By Cedric Manlhiot, Vivek A. Rao, MD PhD, Barry Rubin
| cmajopen.ca
Results: Observed mortality was 1.96%, which was the same as that predicted by the Society of Thoracic Surgeons model (1.96%), but significantly higher than that predicted by the CIHI model (1.03%). Despite both models having similar C statistics (0.756 CIHI; 0.758 Society of Thoracic Surgeons), the CIHI model showed significant underestimation of mortality among patients at higher risk.
Open in Who Shared Issue with article?
See all 28 licensed articles (31 Total)